Notice of Closed Meeting, 17412 [2019-08338]

Download as PDF 17412 Federal Register / Vol. 84, No. 80 / Thursday, April 25, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Administration for Children and Families Notice of Closed Meeting Notice of Closed Meeting Submission for OMB Review; Comment Request Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CE–19–002, Research Grants to Identify Effective Strategies for Opioid Overdose Prevention. Date: June 25–26, 2019. Time: 8:30 a.m.–5:30 p.m., EDT. Place: Hilton Garden Inn Atlanta— Buckhead, 3342 Peachtree Road NE, Atlanta, GA 30326 Agenda: To review and evaluate grant applications. For Further Information Contact: Mikel Walters, Ph.D., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (404) 639–0913, MWalters@ cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—PAR 18–812, NIOSH Member Conflict. Date: June 27, 2019. Time: 1:00 p.m.–4:00 p.m. EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Nina Turner, Ph.D., Scientific Reviewer Officer, Office of Extramural Programs, 1095 Willowdale Road, Morgantown, WV 26506, (304) 285–5976, nxt2@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–08338 Filed 4–24–19; 8:45 am] [FR Doc. 2019–08337 Filed 4–24–19; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P Title: National Evaluation of the Sexual Risk Avoidance Education (SRAE) Program. OMB No.: [NEW]. Description: The Administration for Children and Families (ACF) proposes a data collection effort related to the National Evaluation of the Sexual Risk Avoidance Education (SRAE) Program— National Descriptive Study. The National Descriptive Study (of the National Evaluation of the SRAE Program) has multiple components. This information collection request only pertains to the Early Implementation Study, which will provide an early catalogue of SRAE programs’ implementation. ACF seeks approval to collect the following information: —Survey for Use with SRAE grantees. The purpose of this collection effort is to conduct surveys with administrators/program directors in each of the states/organizations that received SRAE grants to better understand what key decisions states/ organizations made regarding the design of their SRAE-funded programs and why they made those decisions. —Interview Guide for Use with SRAE grantees. The purpose of this collection effort is to conduct semistructured interviews, that follow-on the surveys, with administrators/ program directors in each of the states/organizations that received SRAE grants: the interviews will offer long-answer, qualitative responses to key questions, to better understand what key decisions states/ organizations made regarding the design of their SRAE-funded programs and why they made those decisions. Respondents: State level administrators; Agency administrators; Organization heads; Project directors. khammond on DSKBBV9HB2PROD with NOTICES ANNUAL BURDEN ESTIMATES Total number of respondents Instrument Survey for SRAE Grantees .................................................. Interview Guide for SRAE Grantees .................................... VerDate Sep<11>2014 16:25 Apr 24, 2019 Jkt 247001 PO 00000 Frm 00039 Annual number of respondents 85 85 Fmt 4703 Sfmt 4703 Number of responses per respondent 28 28 E:\FR\FM\25APN1.SGM 1 1 25APN1 Average burden hours per response 1.5 1.5 Annual burden hours 42 42

Agencies

[Federal Register Volume 84, Number 80 (Thursday, April 25, 2019)]
[Notices]
[Page 17412]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08338]



[[Page 17412]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)--RFA-CE-19-002, Research 
Grants to Identify Effective Strategies for Opioid Overdose 
Prevention.
    Date: June 25-26, 2019.
    Time: 8:30 a.m.-5:30 p.m., EDT.
    Place: Hilton Garden Inn Atlanta--Buckhead, 3342 Peachtree Road 
NE, Atlanta, GA 30326
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Mikel Walters, Ph.D., 
Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, 
Mailstop F-63, Atlanta, Georgia 30341, Telephone (404) 639-0913, 
[email protected].
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal 
Register notices pertaining to announcements of meetings and other 
committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and 
Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-08338 Filed 4-24-19; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.